Basic Body Awareness Therapy for Healthy Young Adults
An Investigation Into the Effects of Basic Body Awareness Therapy on Musculoskeletal Pain, Spinal Mobility, Balance and Flexibility
Background:
Musculoskeletal pain, impaired postural control, and reduced movement quality are increasingly observed among young adults, partly due to sedentary lifestyles and insufficient physical activity. Basic Body Awareness Therapy (BBAT) is a physiotherapy-based mind-body approach designed to enhance body awareness, movement quality, balance, and postural stability through controlled functional movements. Although BBAT has demonstrated beneficial effects in various clinical populations, evidence regarding its effectiveness in healthy young adults remains limited.
Objective:This study aims to investigate the effects of a 12-week BBAT program on balance, musculoskeletal pain, spinal mobility, and flexibility in healthy young adults.
Methods:This randomized controlled trial will be conducted at the Healthy Living Laboratory of the University of Health Sciences, Gülhane Faculty of Physiotherapy and Rehabilitation, between June 2026 and May 2027. Healthy individuals aged 18-40 years will be recruited through voluntary participation and social media announcements. Participants will be randomly assigned to either a BBAT intervention group or a control group. The intervention group will participate in supervised BBAT sessions once weekly for 12 weeks, with each session lasting 45-60 minutes, while the control group will receive no intervention. Eligible participants will be individuals aged 18-40 years who have not participated in structured body-awareness-based exercise programs, such as BBAT, yoga, or Pilates, within the previous six months and who are able to complete all assessment procedures independently. Individuals with neurological, vestibular, rheumatological, or severe orthopedic disorders, recent surgery or injury affecting the spine or lower extremities, pregnancy, acute infection, or medication use affecting balance will be excluded.
Spinal mobility and flexibility will be the primary outcome measure. Secondary outcomes will include musculoskeletal pain and balance. Assessments will be performed before and after the intervention period.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Background:
Musculoskeletal pain, postural control impairments, and reduced movement quality are increasingly prevalent among young adults, partly due to sedentary lifestyles and low physical activity levels. Basic Body Awareness Therapy (BBAT) is a physiotherapy-based mind-body approach that aims to improve body awareness, postural stability, movement quality, and balance through controlled functional movements. Although BBAT has demonstrated beneficial effects in various clinical populations, evidence regarding its effectiveness in healthy young adults remains limited.
Objective:
This study aims to investigate the effects of a 12-week BBAT program on musculoskeletal pain, spinal mobility, balance, and flexibility in healthy young adults.
Methods:
This randomized controlled trial will be conducted at the Healthy Living Laboratory of the University of Health Sciences, Gülhane Faculty of Physiotherapy and Rehabilitation, between June 2026 and May 2027. Healthy individuals aged 18-40 years will be recruited through social media announcements and voluntary participation. Participants will be randomly allocated to either an intervention group or a control group.
The intervention group will participate in BBAT sessions once weekly for 12 weeks, with each session lasting 45-60 minutes. The control group will receive no intervention during the study period. Inclusion criteria include being 18-40 years old, not having participated in structured body-awareness-based programs (e.g., BBAT, yoga, or Pilates) within the previous six months, and being able to complete the assessment procedures independently. Individuals with neurological, vestibular, rheumatological, or severe orthopedic disorders, recent surgery or injury affecting the spine or lower extremities, pregnancy, acute infection, or medications affecting balance will be excluded.
Spinal mobility and flexibility will be the primary outcome measure. Secondary outcomes will include musculoskeletal pain and balance. Assessments will be performed before and after the intervention period.
Sample size estimation was conducted using G*Power 3.1 based on a medium effect size (f = 0.25), α = 0.05, power = 80%, two groups, and two measurement points. The minimum required sample size was calculated as 36 participants. Considering a potential dropout rate of 15-20%, at least 40 participants (20 per group) will be recruited.
Hypotheses:
Compared with the control group, participants receiving BBAT are expected to demonstrate significantly greater improvements in (1) spinal mobility , (2) flexibility , (3)musculoskeletal pain, and (4) balance outcomes.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Age between 18 and 40 years.
- Ability to walk independently without assistive devices.
- No participation in structured body-awareness-based exercise programs (e.g., Basic Body Awareness Therapy, yoga, or Pilates) within the previous 6 months.
- Ability to understand study procedures and comply with assessment protocols.
- Willingness to participate and provision of written informed consent.
Exclusion Criteria:
- History of neurological, vestibular, rheumatologic, or severe orthopedic disorders that may affect movement, balance, or mobility.
- History of spinal or lower-extremity surgery or musculoskeletal injury within the previous 6 months.
- Severe musculoskeletal pain limiting participation in assessments or intervention sessions.
- Pregnancy.
- Current use of medications known to affect balance, postural control, or motor performance.
- Presence of acute infection or other acute medical conditions at the time of enrollment.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Control
The control group will be assessed for spinal mobility, flexibility, musculoskeletal pain, and balance at baseline and following a 12-week follow-up period.
Participants in this group will not receive any intervention throughout the study.
|
|
|
Experimental: Exercise
The intervention group will participate in supervised BBAT sessions once weekly for 12 weeks, with each session lasting 45-60 minutes. BBAT exercises include; Grounding Postural balance Co-ordination Breathing Flow Mental awareness |
Participants allocated to the intervention group will receive a 12-week Basic Body Awareness Therapy (BBAT) program. The intervention will be delivered once weekly on the same day and at the same time each week, with each session lasting approximately 45-60 minutes. The BBAT program will consist of structured exercises performed in supine, sitting, and standing positions, focusing on postural alignment, muscle activation and relaxation, breathing awareness, weight transfer, balance control, and movement quality. Individual and partner-based exercises will be used to enhance body awareness, postural stability, and coordinated movement patterns. All sessions will be supervised and conducted by a physiotherapist who has completed BBAT Level III training. Participants will be encouraged to perform the movements with attention to body awareness, balance, breathing, and movement efficiency throughout the intervention period. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Spinal mobility
Prazo: Baseline and Week 12
|
Spinal mobility will be assessed using the Spinal Mouse® system (Idiag AG, Fehraltorf, Switzerland).
Measurements will be obtained in neutral standing, maximal flexion, maximal extension, and maximal lateral flexion positions.
Two measurements will be recorded for each position, and the average value will be used for analysis.
|
Baseline and Week 12
|
|
Flexibility
Prazo: Baseline and Week 12
|
Flexibility of the lumbar region and lower extremities will be evaluated using the Sit-and-Reach Test.
Participants will perform three trials, and the best score (cm) will be recorded for analysis.
|
Baseline and Week 12
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Musculoskeletal pain
Prazo: Baseline and Week 12
|
Musculoskeletal pain and discomfort will be assessed using the Cornell Musculoskeletal Discomfort Questionnaire (CMDQ).
The CMDQ evaluates the frequency, severity, and functional impact of discomfort in different body regions.
Total CMDQ scores will be used for analysis.
|
Baseline and Week 12
|
|
Balance
Prazo: Baseline and Week 12
|
Balance performance will be assessed using the HUR Balance® system.
Static and dynamic postural control parameters, including center-of-pressure sway and stability measures, will be recorded according to the standardized testing protocol.
|
Baseline and Week 12
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- SBUBBAT
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .